Healthcare / Medical Care FacilitiesMilan
$5.26
+0.06 (+1.14%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $15.5M · quality 67.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
54/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$464M
P/E
21.9x
↑EV/EBITDA
9.2x
↓ROE
6.9%
↑Gross Margin
84.6%
↑Debt/Equity
0.67
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+14.9%
FCF CAGR
-18.7%
FCF margin
3.2%
FCF / Net income
0.66x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $485.1M · net income $23.4M · FCF $15.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $485.1M | $485.1M | $467.8M | $366.1M | $320.0M |
| Net Income | $23.4M | $23.4M | $21.7M | $20.8M | $21.4M |
| EBITDA | $72.7M | $72.7M | $69.9M | $60.7M | $49.9M |
| EPS | 0.26 | 0.26 | 0.24 | 0.18 | 0.24 |
| Gross Margin | 84.6% | 84.6% | 85.0% | 86.4% | 86.0% |
| Operating Margin | 11.4% | 11.4% | 11.7% | 12.7% | 11.7% |
| Net Margin | 4.8% | 4.8% | 4.6% | 5.7% | 6.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.67 | 0.67 | 0.71 | 0.76 | 0.63 |
| Current Ratio | 1.15 | 1.15 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $15.5M | $15.5M | $13.4M | $32.9M | $28.9M |
| Returns | |||||
| ROE | 6.9% | 6.9% | 6.7% | 7.0% | 7.7% |
| Valuation | |||||
| P/E | 21.92 | 21.92 | 22.58 | 24.72 | 16.21 |
| EV/EBITDA | 9.24 | 9.24 | 9.91 | 9.88 | 9.83 |
| P/B | 1.37 | 1.37 | 1.52 | 1.32 | 1.24 |
| Growth & Yield | |||||
| Revenue Growth | 3.7% | 3.7% | 27.8% | 14.4% | — |
| EPS Growth | 8.3% | 8.3% | 33.3% | -25.0% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
21.5%
EPS terminal req.
$0.47
Spread vs growth
-13.2%
5Y implied EPS CAGR
16.8%
EPS terminal req.
$0.56
Spread vs growth
-8.4%
10Y implied EPS CAGR
13.3%
EPS terminal req.
$0.91
Spread vs growth
-5.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+3.7%
Start / end P/E
21.7x → 20.5x
EPS bridge
0.24 → 0.26
Residual
-0.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.